Pennsylvania Drug and Alcohol Inpatient Licensing: Chapter 709 Requirements

Flag of Pennsylvania — Pennsylvania license reinstatement

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Apply now: Request for Licensing Application Packet Form | Questions: ra-licensuredivision@pa.gov

Pennsylvania Drug and Alcohol Inpatient Licensing: Chapter 709 Requirements

Residential substance use treatment in Pennsylvania runs through DDAP’s Chapter 709 (Standards for Licensure of Freestanding Treatment Facilities), and the internal structure of that chapter matters as much as the fact that it exists.

Your license expires every year, on purpose

A DDAP license under Chapter 709 is valid for one year from issuance, not longer. Before it expires, DDAP notifies the facility of the date for an annual on-site inspection tied to renewal, so this isn’t a passive renewal you can let happen on paperwork alone. Every year, your facility goes back through a real inspection.

Full and provisional licenses aren’t the same status

Chapter 709 has two kinds of license. A full license (§ 709.12) issues after an on-site inspection finds the facility meets the chapter. A provisional license (§ 709.13) covers a facility that has substantially but not completely complied, is following an approved course of correction, and has no deficiencies that endanger clients. It lasts no more than 6 months and can be renewed no more than three times, so a facility can’t sit on provisional status indefinitely. Section 709.14, titled “Restriction on license,” isn’t a third status. It says the license belongs to the named person, facility, premises and activities, can’t be transferred, and requires you to report changes in ownership, name, location, activity, capacity or closure within 90 days.

Recovery houses live in a different chapter entirely

Recovery house licensing comes from its own article of The Administrative Code of 1929 (71 P.S. §§ 613.11 to 613.18), and DDAP wrote its standards as a separate Chapter 717 (Standards for Drug and Alcohol Recovery House Licensure) rather than folding them into Chapter 709. If you’re running a recovery house alongside a treatment program, don’t assume 709’s standards apply to the recovery house piece. They don’t. Whether a particular house has to be licensed turns on the statute’s funding and referral triggers, which we couldn’t re-check for this update, so confirm your house’s status with DDAP before you assume a private-pay model keeps you outside Chapter 717.

ASAM level certification through CARF

If you want a residential program’s ASAM level confirmed by an outside body, CARF offers a separate route. Its ASAM Level of Care Certification, run in partnership with ASAM, covers adult residential Levels 3.1, 3.5 and 3.7. Your Chapter 709 license may say nothing about it. A payer who wants to check runs the level through the certification filter in CARF’s provider search.

Medication-assisted treatment

Methadone treatment runs through Chapter 715, which is an approval layered on top of a DDAP facility license, not a license of its own. A narcotic treatment program needs the DDAP license, DDAP’s Chapter 715 approval, a DEA registration and SAMHSA certification before it can operate. A residential facility without that approval needs an actual coordination relationship with an approved narcotic treatment program for any resident who needs it, named specifically rather than described in the abstract. Documenting the specific program you coordinate with is the kind of clinical capability DDAP expects to see on paper, not just claimed in a policy manual. Buprenorphine and naltrexone are more flexible: any practitioner whose DEA registration covers Schedule III can prescribe buprenorphine since the federal waiver requirement ended in 2023, and naltrexone needs only ordinary prescribing privileges.

Ketamine in a Chapter 709 Residential Program

Drawn from DDAP’s licensing structure and change-reporting rules, plus Pennsylvania’s case law on corporate practice. Neither DDAP nor the State Board of Nursing has addressed psychiatric ketamine directly, so this is an interpretation to confirm with DDAP before launch.

DDAP licenses facilities by drug and alcohol activity, and ketamine for depression isn’t one of them. That makes it a medical service delivered by the facility’s prescribers inside a licensed setting, not a line item DDAP approves on its own. It still touches the license. DDAP requires a facility to report a change in activity within 90 days, and failing to report a listed change triggers automatic expiration of the license. Whether a brand-new activity can be handled by that notice or needs a fresh application packet isn’t spelled out in § 709.14, so ask DDAP’s Division of Licensing Operations which path a ketamine protocol falls under before the first dose, since the annual Chapter 709 inspection will see it either way.

No Pennsylvania State Board of Nursing guidance specific to psychiatric ketamine turned up in research for this page, so the facility’s own protocol carries the dosing limits, monitoring and on-site coverage. Pennsylvania nurse practitioners prescribe under a collaborative agreement with physicians, and that agreement should name ketamine if an NP will order it.

Who Belongs in the Chair

In a Chapter 709 program, ketamine makes sense for a resident whose withdrawal is behind them and whose depression or PTSD has shrugged off ordinary medication. A resident who has used ketamine or other dissociatives recreationally shouldn’t get it. Ketamine also isn’t a Chapter 715 narcotic treatment medication or an addiction medication of any kind, so it doesn’t replace the methadone coordination relationship described above.

After Discharge

Watching a resident through the days between early sessions is the part of a 709 stay no clinic can reproduce, and when a resident responds, the next stop after discharge is usually an outpatient ketamine clinic. Pennsylvania’s corporate practice of medicine rule comes from case law rather than a statute, and management agreements that split profits with a non-physician company draw the most scrutiny. A physician-owned professional corporation paired with an MSO paid a fixed, fair-market fee is the usual answer. The details are in the ketamine section of Pennsylvania Drug and Alcohol Outpatient Licensing: DDAP Requirements. Referrals from a residential program into an affiliated clinic also need counsel’s review under the federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220).

Staffing a residential program

How you mix credentialed and still-certifying counselors under one supervisor is the real lever operators have on residential staffing costs. Pennsylvania addiction counselors earn a median of $58,320 a year, close to the national median. A residential Chapter 709 program with a program director and several CADC-credentialed counselors commonly runs $250,000 to $330,000 a year in clinical payroll, with Chapter 704’s more intensive staffing requirements pushing residential and detox costs above what a comparable outpatient program would run. Those figures look steep in isolation, and most Pennsylvania operators never actually pay them in full. A clinical director supervising several counselors who are still logging the work experience and supervision hours certification requires (the CAAC alone takes years of supervised full-time work, so check the Pennsylvania Certification Board’s current hour counts), at lower wages than certified staff, can cut clinical staffing costs by 40 to 60% compared to an all-CADC roster. On the nursing side, most residential programs can run with one RN overseeing several LPNs rather than an all-RN team. Once your program model is confirmed, the actual staffing matrix and cost estimate follow, mitigation strategies included.

How to Submit Your DDAP Application

Start with the Request for Licensing Application Packet Form, selecting the drug and alcohol activities your facility will provide, and email it to ra-licensureapps@pa.gov. For general questions, DDAP’s Division of Licensing Operations can be reached at ra-licensuredivision@pa.gov.

Frequently Asked Questions

Is a provisional DDAP license the same as full licensure?

No. A provisional license under § 709.13 is issued for no more than 6 months to a facility that is close to compliance and working through an approved correction plan, and it can be renewed no more than three times. A full license issues only once an inspection shows the facility meets Chapter 709.

Does operating a recovery house require DDAP licensure under Chapter 709?

No. Recovery houses fall under Chapter 717, a separate chapter from treatment facilities, written under 71 P.S. §§ 613.11 to 613.18. Which houses must hold that license depends on the statute’s funding and referral rules, so check with DDAP before relying on a private-pay exemption.

Does my DDAP license ever stop requiring annual inspection?

No. A Chapter 709 license is valid for one year from issuance, and DDAP notifies the facility ahead of an on-site inspection tied to every renewal. There’s no point at which this becomes a paperwork-only renewal.

See our Pennsylvania Behavioral Health Licensing page for the full picture.

This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

Sorting out your license status under Chapter 709? Let’s talk it through.

Sources

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Top